Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts (REPERFUSE)

NCT04667078 is registered in ClinicalTrials.gov with Fondation Ophtalmologique Adolphe de Rothschild as lead sponsor.

NCT NCT04667078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04667078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts (REPERFUSE)
Lead sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Phase
Phase 3
Overall status
Suspended
Start date
March 2, 2022
Completion date
December 21, 2027
Enrollment
368 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemia